Table 7.

Rat serum alkaline phosphatase ALP- and γ-glutamyl transpeptidase (GGT)-specific activities in control and treated samples. Cypermethrin, carbendazim and cypermethrin + carbendazim (each) at 12- and 24-h duration

	ALP (IU/mg protein/ml × 10−2)		GGT (IU/mg protein/ml × 10−2)
Groups	12 h	24 h	12 h	24 h
CONTROL	0.829 ± 0.04	0.605 ± 0.05	0.0159 ± 0.0007	0.013 ± 0.0006
CYP-0.06 mg/kg bw	0.903 ± 0.04a	0.714 ± 0.04b	0.0213 ± 0.0006a,d	0.0184 ± 0.0005a,d
CYP-0.12 mg/kg bw	0.511 ± 0.04e,d	0.803 ± 0.04b,d	0.0162 ± 0.0006	0.0154 ± 0.0004d
CYP-0.30 mg/kg bw	0.858 ± 0.04	0.768 ± 0.04b,d	0.0146 ± 0.0006	0.014 ± 0.0007a
CYP-0.60 mg/kg bw	0.828 ± 0.07	0.744 ± 0.05b,a	0.0182 ± 0.0007d	0.017 ± 0.0009a,d
CAR-0.48 mg/kg bw	0.561 ± 0.03d	0.597 ± 0.03a	0.0167 ± 0.0005	0.010 ± 0.0005a,d
CAR-0.96 mg/kg bw	0.600 ± 0.03b,d	0.660 ± 0.04b	0.024 ± 0.0005a,d	0.011 ± 0.0007a,d
CAR-2.4 mg/kg bw	0.609 ± 0.04b,d	0.680 ± 0.05a	0.0173 ± 0.0006	0.014 ± 0.0007a
CAR-4.8 mg/kg bw	0.792 ± 0.04b	0.770 ± 0.05b,d	0.0191 ± 0.0008d	0.0089 ± 0.0006b,d
CYP-0.06 + CAR-0.48 mg/kg bw	0.793 ± 0.04a	0.686 ± 0.04b	0.0157 ± 0.0004	0.0202 ± 0.0010a,d
CYP-0.12 + CAR-0.96 mg/kg bw	0.692 ± 0.03b,d	0.703 ± 0.06b	0.0165 ± 0.0006	0.0222 ± 0.0007a,d
CYP-0.30 + CAR-2.4 mg/kg bw	0.689 ± 0.04b,d	0.695 ± 0.04a	0.0232 ± 0.0009a,d	0.0198 ± 0.0008a,d
CYP-0.60 + CAR-4.8 mg/kg bw	0.769 ± 0.04a	0.660 ± 0.07a	0.0152 ± 0.0004	0.0158 ± 0.0005d

Values are mean ± SEM from 6 rats in each group.

^aP < 0.05,

^bP < 0.01 and

^eP < 0.001: Compared between the control and treated groups.

^cP < 0.05 and

^dP < 0.01: Compared between the treated groups. Data analysed by one-way anova followed by Dunnett test.